Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jan;26(1):13-6.
doi: 10.1002/dmrr.1050.

Diabetes and microvascular pathophysiology: role of epidermal growth factor receptor tyrosine kinase

Khalid Matrougui  1
Affiliations
Review

Diabetes and microvascular pathophysiology: role of epidermal growth factor receptor tyrosine kinase

Khalid Matrougui. Diabetes Metab Res Rev. 2010 Jan.

Abstract

Type 2 diabetes is responsible for the increased prevalence of ischaemic heart disease, generally related to coronary artery disease, which is associated with increased morbidity and death in diabetic patients. Epidermal growth factor receptor (EGFR) tyrosine kinase, one of the many factors involved in cell growth and migration, has been shown to be key element in the development of microvessel myogenic tone. In a recent study, we have shown that microvascular dysfunction in type 2 diabetes is dependent on the exacerbation of the EGFR tyrosine kinase phosphorylation. Thus, further elucidation of this EGFR transactivation and down stream signalling will offer a new direction to investigate the mechanism of microvascular dysfunction responsible for heart disease that occurs in type 2 diabetes. In this review, we discuss the link between the EGFR transactivation and microvascular dysfunction that occurs in type 2 diabetes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Figure 2
Figure 2
Figure 3
Figure 3
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001 Sep;44(Suppl 2):S14–21. - PubMed
    1. Mahmud A, Feely J. Arterial stiffness and the renin-angiotensin-aldosterone system. J Renin Angiotensin Aldosterone Syst. 2004 Sep;5(3):102–108. - PubMed
    1. Kassab GS, Molloi S. Cross-sectional area and volume compliance of porcine left coronary arteries. Am J Physiol Heart Circ Physiol. 2001 Aug;281(2):H623–H628. - PubMed
    2. Hoffman JI, Spaan JA. Pressure-flow relations in coronary circulation. Physiol Rev. 1990 Apr;70(2):331–390. - PubMed
    1. Zhai P, Galeotti J, Liu J, Holle E, Yu X, Wagner T, Sadoshima J. An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy. Circ Res. 2006 Sep 1;99(5):528–536. - PubMed
    1. Lucchesi PA, Sabri A, Belmadani S, Matrougui K. Involvement of metalloproteinases 2/9 in epidermal growth factor receptor transactivation in pressure-induced myogenic tone in mouse mesenteric resistance arteries. Circulation. 2004 Dec 7;110(23):3587–3593. - PubMed

Publication types

MeSH terms